Recombinant EGFR (Panitumumab Biosimilar) 抗体
Quick Overview for Recombinant EGFR (Panitumumab Biosimilar) 抗体 (ABIN7200662)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
-
-
原理
- Panitumumab Biosimilar, Human EGFR/ErbB-1/HER1 Monoclonal Antibody
-
特异性
- The monoclonal antibody panitumumab biosimilar specifically binds to the human EGFR, ErbB-1 and HER1.
-
产品特性
- Recombinant Humanized IgG2 Monoclonal Antibody.
-
纯化方法
- Protein A affinity column
-
纯度
- > 95% by SDS-PAGE under reducing conditions and HPLC.
-
过滤
- 0.2 μm filtered
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method.
-
免疫原
- The monoclonal antibody panitumumab biosimilar was produced in the Panitumumab biosimilar CHO stable cell line.
-
亚型
- IgG2 kappa
-
-
-
-
应用备注
- ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by panitumumab.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS, pH 7.4, no stabilizers or preservatives.
-
储存液
- Without preservative
-
注意事项
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
-
有效期
- 12 months
-
-
- EGFR (Panitumumab Biosimilar)
-
物质类
- Biosimilar
-
背景
- Panitumumab, a fully anti-EGFR (epidermal growth factor receptor, EGF receptor, ErbB-1 and HER1 in humans) human monoclonal antibody, is used for the treatment of refractory EGFR-expressing metastatic colorectal cancer in patients with non-mutated (wild-type) KRAS".
抗原
-